Differential roles of RIG-I like receptors in SARS-CoV-2 infection
- PMID: 34488908
- PMCID: PMC8421188
- DOI: 10.1186/s40779-021-00340-5
Differential roles of RIG-I like receptors in SARS-CoV-2 infection
Abstract
Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated protein 5 (MDA5) sense viral RNA and activate antiviral immune responses. Herein we investigate their functions in human epithelial cells, the primary and initial target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A deficiency in MDA5, RIG-I or mitochondrial antiviral signaling protein (MAVS) enhanced viral replication. The expression of the type I/III interferon (IFN) during infection was impaired in MDA5-/- and MAVS-/-, but not in RIG-I-/-, when compared to wild type (WT) cells. The mRNA level of full-length angiotensin-converting enzyme 2 (ACE2), the cellular entry receptor for SARS-CoV-2, was ~ 2.5-fold higher in RIG-I-/- than WT cells. These data demonstrate MDA5 as the predominant SARS-CoV-2 sensor, IFN-independent induction of ACE2 and anti-SARS-CoV-2 role of RIG-I in epithelial cells.
Keywords: Melanoma differentiation-associated protein 5; Pathogen pattern recognition receptor; Retinoic acid-inducible gene I; SARS-CoV-2.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Update of
-
Differential roles of RIG-I-like receptors in SARS-CoV-2 infection.bioRxiv [Preprint]. 2021 Feb 11:2021.02.10.430677. doi: 10.1101/2021.02.10.430677. bioRxiv. 2021. Update in: Mil Med Res. 2021 Sep 7;8(1):49. doi: 10.1186/s40779-021-00340-5. PMID: 33594370 Free PMC article. Updated. Preprint.
Similar articles
-
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling.Signal Transduct Target Ther. 2020 Dec 28;5(1):299. doi: 10.1038/s41392-020-00438-7. Signal Transduct Target Ther. 2020. PMID: 33372174 Free PMC article.
-
RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.Front Immunol. 2021 Jun 25;12:700926. doi: 10.3389/fimmu.2021.700926. eCollection 2021. Front Immunol. 2021. PMID: 34249006 Free PMC article.
-
SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.J Med Virol. 2021 Sep;93(9):5376-5389. doi: 10.1002/jmv.27050. Epub 2021 May 9. J Med Virol. 2021. PMID: 33913550 Free PMC article.
-
Negative regulators of the RIG-I-like receptor signaling pathway.Eur J Immunol. 2017 Apr;47(4):615-628. doi: 10.1002/eji.201646484. Eur J Immunol. 2017. PMID: 28295214 Free PMC article. Review.
-
MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients.Clin Rev Allergy Immunol. 2024 Dec;67(1-3):58-72. doi: 10.1007/s12016-024-09008-z. Epub 2024 Oct 26. Clin Rev Allergy Immunol. 2024. PMID: 39460899 Review.
Cited by
-
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment.Cell Discov. 2022 May 10;8(1):42. doi: 10.1038/s41421-022-00408-z. Cell Discov. 2022. PMID: 35538050 Free PMC article. No abstract available.
-
Pushing the frontiers of military medical excellence: updates, progress and future needs.Mil Med Res. 2022 Jun 10;9(1):27. doi: 10.1186/s40779-022-00388-x. Mil Med Res. 2022. PMID: 35681166 Free PMC article.
-
The signal pathways and treatment of cytokine storm in COVID-19.Signal Transduct Target Ther. 2021 Jul 7;6(1):255. doi: 10.1038/s41392-021-00679-0. Signal Transduct Target Ther. 2021. PMID: 34234112 Free PMC article. Review.
-
Recurrent viral capture of cellular phosphodiesterases that antagonize OAS-RNase L.Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2312691121. doi: 10.1073/pnas.2312691121. Epub 2024 Jan 26. Proc Natl Acad Sci U S A. 2024. PMID: 38277437 Free PMC article.
-
Vaccines against SARS-CoV-2 variants and future pandemics.Expert Rev Vaccines. 2022 Oct;21(10):1363-1376. doi: 10.1080/14760584.2022.2110075. Epub 2022 Aug 12. Expert Rev Vaccines. 2022. PMID: 35924678 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous